pentobarbital will reduce the level or outcome of fentanyl transmucosal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Coadministration of fentanyl with CYP3A4 inducers could lead to the minimize in fentanyl plasma concentrations, deficiency of efficacy or, maybe, enhancement of the withdrawal syndrome in